Baxter International Inc. (NYSE:BAX) Stock Has Average Target Price of $22.45

Posted by Geri Gentry on Oct 3rd, 2026

Shares of Baxter International Inc. (NYSE:BAX – Get Free Report) have been given an average recommendation of “Hold” by the thirteen brokerages that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating on the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $22.45.

A number of research analysts have recently commented on the stock. TD Cowen boosted their price target on shares of Baxter International from $20.00 to $24.00 and gave the company a “hold” rating in a research report on Monday, July 27th. Wall Street Zen upgraded shares of Baxter International from a “hold” rating to a “buy” rating in a report on Saturday, August 1st. Stifel Nicolaus boosted their target price on Baxter International from $19.00 to $24.00 and gave the company a “hold” rating in a research note on Tuesday, July 28th. UBS Group raised their price target on Baxter International from $19.00 to $25.00 and gave the stock a “hold” rating in a research note on Tuesday, July 28th. Finally, Zacks Research raised Baxter International from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 11th.

Get Our Latest Research Report on BAX

Baxter International Trading Down 0.7%

NYSE BAX opened at $23.48 on Wednesday. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 1.39. The firm has a market capitalization of $12.14 billion, a P/E ratio of -11.34, a PEG ratio of 3.58 and a beta of 0.65. The business has a fifty day simple moving average of $25.32 and a 200 day simple moving average of $21.30. Baxter International has a 12 month low of $15.73 and a 12 month high of $30.00.

Baxter International (NYSE:BAX – Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.19. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%.The business had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $2.80 billion. During the same quarter in the previous year, the firm earned $0.59 earnings per share. The business’s revenue was up 5.3% on a year-over-year basis. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. On average, analysts predict that Baxter International will post 2.04 EPS for the current fiscal year.

Baxter International Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Investors of record on Friday, August 28th were issued a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Friday, August 28th. Baxter International’s dividend payout ratio is currently -1.93%.

Institutional Trading of Baxter International

Hedge funds and other institutional investors have recently bought and sold shares of the business. CX Institutional grew its position in shares of Baxter International by 2.3% during the 3rd quarter. CX Institutional now owns 19,858 shares of the medical instruments supplier’s stock valued at $477,000 after acquiring an additional 448 shares during the period. Baird Financial Group Inc. increased its holdings in Baxter International by 1.1% in the 2nd quarter. Baird Financial Group Inc. now owns 44,722 shares of the medical instruments supplier’s stock worth $953,000 after acquiring an additional 476 shares in the last quarter. Empirical Finance LLC raised its position in Baxter International by 3.5% during the second quarter. Empirical Finance LLC now owns 18,170 shares of the medical instruments supplier’s stock worth $387,000 after acquiring an additional 608 shares during the period. CYBER HORNET ETFs LLC boosted its stake in shares of Baxter International by 52.4% in the second quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier’s stock worth $46,000 after acquiring an additional 740 shares during the last quarter. Finally, Bruce G. Allen Investments LLC grew its stake in Baxter International by 22.8% during the 4th quarter. Bruce G. Allen Investments LLC now owns 4,452 shares of the medical instruments supplier’s stock valued at $85,000 after acquiring an additional 827 shares in the last quarter. Hedge funds and other institutional investors own 90.19% of the company’s stock.

About Baxter International

(Get Free Report)

Baxter International Inc is a global healthcare company that develops and markets products used in hospitals, outpatient facilities and other care settings. Its portfolio includes intravenous solutions and administration sets, infusion pumps, parenteral nutrition products, injectable medicines, surgical products and systems for medication preparation and delivery.

The company also provides products and technologies that support anesthesia, critical care, patient monitoring and other hospital workflows.